QGEN — QIAGEN N.V.
—
NYSE ·
Health Care ·
Biotechnology ·
CIK 1015820 ·
Netherlands
Last close
$35.54
Market Cap
$7.33B
52W High
$49.86
52W Low
$32.53
ADV30
2,249,681
Next earnings
2026-08-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 492,320,000 | 309,603,000 | 116,626,000 | 68,043,000 | 5,782,065,000 | 646,289,000 | 2,450,359,000 |
| Dec 2025 | 540,420,000 | 325,269,000 | 121,880,000 | 107,829,000 | 6,281,232,000 | 839,005,000 | 2,503,078,000 |
| Sep 2025 | 532,583,000 | 331,259,000 | 137,293,000 | 130,043,000 | 6,553,497,000 | 1,355,594,000 | 2,904,082,000 |
| Jun 2025 | 533,540,000 | 334,286,000 | 135,974,000 | 96,250,000 | 5,823,758,000 | 733,815,000 | 2,318,268,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$654,326,000
Investing CF
$-305,279,000
Financing CF
$-178,976,000
CapEx
$-207,126,000
Dividends Paid
$1,000
Buybacks
$0
EPS Diluted TTM
$2.04
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$2,748,390,000
Inventory
$301,888,000
Receivables
$520,033,000
ST Investments
$259,913,000
EBIT TTM
$523,521,000
Pretax Income TTM
$490,265,000
Interest Exp TTM
$33,256,000
Analysts
14
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,098,862,976
EBITDA
$727,684,992
Free Cash Flow
$238,874,368
Enterprise Value
$8,274,586,624
Total Cash
$646,289,024
Total Debt
$1,667,063,040
Shares Out
206,250,000
Trailing EPS
$1.96
Book Value
$16.15
ROE
11.9%
ROA
6.0%
Div Yield
1.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,089,999,000 | 520,310,000 | 424,880,000 | 6,281,232,000 | 2,503,078,000 | — | 654,326,000 |
| Dec 2024 | 1,978,214,000 | 199,899,000 | 83,591,000 | 5,689,622,000 | 2,122,283,000 | — | 673,551,000 |
| Dec 2023 | 1,965,311,000 | 445,247,000 | 341,303,000 | 6,115,190,000 | 2,307,426,000 | — | 459,455,000 |
| Dec 2022 | 2,141,518,000 | 576,228,000 | 423,211,000 | 6,287,735,000 | 2,821,124,000 | — | 715,264,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$2.64
Max Pain — expiry 2026-06-18
max pain strike: $35.00 · spot: $35.54 · call oi: 11,858 · put oi: 1,319
Expected Move to 2026-06-18:
±$2.73
(7.67%) —
implied range
$32.82 –
$38.27
· ATM straddle on $35.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | $7.24B | $50.11 | — |
| TECH | BIO-TECHNE Corp | $7.51B | $47.97 | — |
| IMVT | Immunovant, Inc. | $6.95B | $33.83 | — |
| KYMR | Kymera Therapeutics, Inc. | $6.64B | $80.77 | — |
| HALO | HALOZYME THERAPEUTICS, INC. | $8.15B | $68.72 | — |
News headlines (Yahoo Finance, 1h cache)
[Latest] Global Genome Editing Market Size/Share Worth USD 55.7 Billion by 2035 at a 17.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate,
2026-05-21 17:30 · Yahoo
NVIDIA Qiagen Alliance Extends AI Reach Into Drug Discovery Workflows
2026-05-21 13:15 · Yahoo
QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows
2026-05-20 20:05 · Yahoo
Abbott's Biosimilar Push to Help Sustain EPD Growth Momentum
2026-05-20 12:37 · Yahoo
3 Stocks in Focus That Recently Declared Dividend Hikes Amid High Inflation
2026-05-20 12:33 · Yahoo
QIAGEN and NVIDIA partner on AI drug discovery
2026-05-20 10:22 · Yahoo
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
2026-05-19 20:05 · Yahoo
Nucleic Acid Isolation and Purification Market Report 2026-2030: Trends, Challenges and Competitive Analysis Featuring Thermo Fisher Scientific, Merck, QIAGEN, and Roche
2026-05-12 15:13 · Yahoo
QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting
2026-05-12 06:00 · Yahoo
Deciphering Qiagen (QGEN) International Revenue Trends
2026-05-11 13:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.